Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
Roskams, T. A., Theise N. D., Balabaud C., Bhagat G., Bhathal P. S., Bioulac-Sage P., et al. (2004).  Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.. Hepatology. 39(6), 1739-45.
Paschos, P., & Paletas K. (2009).  Non alcoholic fatty liver disease and metabolic syndrome.. Hippokratia. 13(1), 9-19.
Koumarianou, A., Fountzilas G., Kosmidis P., Klouvas G., Samantas E., Kalofonos C., et al. (2009).  Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.. J Chemother. 21(5), 573-83.
Pataka, A., Paspala A., Sourla E., Bagalas V., & Argyropoulou P. (2013).  Non traumatic liver herniation due to persistent cough mimicking a pulmonary mass.. Hippokratia. 17(4), 376-7.
Maladaki, A., Yavropoulou M. P., Kotsa K., Tranga T., Ventis S., & Yovos J. G. (2012).  Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6.. Hormones (Athens). 11(1), 104-8.
Polyzos, S. A., & Mantzoros C. S. (2016).  Nonalcoholic fatty future disease.. Metabolism. 65(8), 1007-16.
Papagianni, M., & Tziomalos K. (2018).  Non-alcoholic fatty liver disease: an emerging predictor of stroke risk, severity and outcome.. Eur J Neurol. 25(4), 610-611.
Polyzos, S. A., & Kountouras J. (2023).  Nonalcoholic fatty liver disease and Helicobacter pylori infection. Is it time to address this potential relationship?. Curr Vasc Pharmacol.
Polyzos, S. A., Chrysavgis L., Vachliotis I. D., Chartampilas E., & Cholongitas E. (2023).  Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.. Semin Cancer Biol. 93, 20-35.
Vachliotis, I. D., Anastasilakis A. D., Goulas A., Goulis D. G., & Polyzos S. A. (2022).  Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.. Diabetes Obes Metab. 24(9), 1702-1720.
Polyzos, S. A., Goulis D. G., & Kountouras J. (2015).  Nonalcoholic fatty liver disease and polycystic ovary syndrome.. Ann Hepatol. 14(6), 941-3.
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.. Angiology. 64(8), 572-5.
Tziomalos, K., Athyros V. G., Paschos P., & Karagiannis A. (2015).  Nonalcoholic fatty liver disease and statins.. Metabolism. 64(10), 1215-23.
Muzurović, E., Polyzos S., Mikhailidis D., Borozan S., Novosel D., Cmiljanić O., et al. (2022).  Non-alcoholic fatty liver disease in children.. Curr Vasc Pharmacol.
Polyzos, S. A., Mousiolis A., Mintziori G., & Goulis D. G. (2020).  Nonalcoholic fatty liver disease in males with low testosterone concentrations.. Diabetes Metab Syndr. 14(5), 1571-1577.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2012).  Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.. Curr Vasc Pharmacol. 10(2), 162-72.
Polyzos, S. A., Goulis D. G., Kountouras J., Mintziori G., Chatzis P., Papadakis E., et al. (2014).  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.. Hormones (Athens). 13(4), 519-31.
Paschou, S. A., Polyzos S. A., Anagnostis P., Goulis D. G., Kanaka-Gantenbein C., Lambrinoudaki I., et al. (2019).  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.. Endocrine.
Macut, D., Tziomalos K., Božić-Antić I., Bjekić-Macut J., Katsikis I., Papadakis E., et al. (2016).  Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.. Hum Reprod. 31(6), 1347-53.
Polyzos, S. A., Kountouras J., Anastasiadis S., Doulberis M., & Katsinelos P. (2018).  Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?. Hepatology. 68(1), 389.
Vachliotis, I., Goulas A., Papaioannidou P., & Polyzos S. A. (2021).  Nonalcoholic fatty liver disease: lifestyle and quality of life.. Hormones (Athens).
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2012).  Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.. J Clin Gastroenterol. 46(4), 272-84.
Polyzos, S. A., Papaefthymiou A., Doulberis M., & Kountouras J. (2023).  Nonalcoholic fatty liver disease test: an external validation cohort.. Hormones (Athens).
Polyzos, S. A., Kountouras J., & Zavos C. (2009).  Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.. Curr Mol Med. 9(3), 299-314.
Pafili, K., Paschou S. A., Armeni E., Polyzos S. A., Goulis D. G., & Lambrinoudaki I. (2022).  Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.. J Endocrinol Invest.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές